🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Promyelocytic Leukemia, Adult Acute

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... NCT02390752Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: TURALIO(R) RWE of 1st Line Treatment With ATO/ATRA for Adult APL NCT04897490n/a6 sites📍 La Plata📍 Paraná📍 Posadas Grupo Argentino de Tratamiento de la Leucemia Aguda · Tests: Evaluation of first line treatment with ATO/ATRA outcome Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia NCT07504458Phase 335 sites📍 Birmingham📍 Duarte📍 Irvine Quetzal Therapeutics · Tests: QTX-2101 + ATRA, IV arsenic trioxide (ATO) + ATRA
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy